Financing
Debt Repayments
ResMed Debt Repayments decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Debt Repayments shows a downward trend with a -49.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Consistent repayment signals a strengthening balance sheet and a reduction in financial risk or leverage.
Detailed definition
The cash used to pay down the principal on outstanding loans, bonds, or commercial paper. This reduces the company's tot...
Peer comparison
Debt-heavy industries show high activity here; tech firms often use it to manage the maturity profile of their corporate bonds.
Metric ID:
debt_repaymentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.00M | $0.00 | $136.00M | $0.00 | $30.00M | $30.00M | $15.00M | $215.00M | $145.00M | $185.00M | $130.00M | $220.00M | $300.00M | $30.00M | $5.00M | $0.00 | $5.00M | $0.00 | $5.00M | $0.00 |
| QoQ Change | — | -100.0% | — | -100.0% | — | +0.0% | -50.0% | >999% | -32.6% | +27.6% | -29.7% | +69.2% | +36.4% | -90.0% | -83.3% | -100.0% | — | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | -60.5% | — | -89.0% | — | +383.3% | +516.7% | +766.7% | +2.3% | +106.9% | -83.8% | -96.2% | -100.0% | -98.3% | -100.0% | +0.0% | — |
Range$0.00 – $300.00M
CAGR-100.0%
Avg YoY Growth+88.3%
Median YoY Growth-60.5%
Debt Repayments at Other Companies
Frequently Asked Questions
- What is ResMed's debt repayments?
- ResMed (RMD) reported debt repayments of $0.00 in Q1 2026.
- What is the long-term trend for ResMed's debt repayments?
- Over 4 years (2021 to 2025), ResMed's debt repayments has grown at a -49.4% compound annual growth rate (CAGR), from $612.00M to $40.00M.
- What does debt repayments mean?
- The amount of money a company spent to pay back its borrowed debt.